SQZ - Sqz Biotechnologies Co - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-5.47. This is a potential upside of $-5.52 (-11040%) from yesterday's end of day stock price of $0.05.

Sqz Biotechnologies Co's activity chart (see below) currently has 9 price targets and 8 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 63 days.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 02-Dec-2022. First documented stock forecast 23-Nov-2020.

Best performing analysts who are covering SQZ - Sqz Biotechnologies Co:

Geulah Livshits Thomas Shrader Emily Bodnar Tazeen Ahmad

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 02-Dec-2022

$10

3 years 1 months 21 days ago
(02-Dec-2022)

1/1 (100%)

$-19.2 (-65.75%)

54

Buy

Since 25-May-2022

$4

$3.95 (7900.00%)

$17

3 years 1 months 22 days ago
(01-Dec-2022)

2/2 (100%)

$-13.8 (-77.53%)

198

Buy

$2

$1.95 (3900.00%)

$37

3 years 1 months 22 days ago
(30-Nov-2022)

0/2 (0%)

$0.22 (12.36%)

Buy

$40

3 years 3 months 17 days ago
(05-Oct-2022)

0/1 (0%)

$10.69 (36.47%)

Show more analysts

Please expand the browser size to see the chart

What is SQZ (Sqz Biotechnologies Co) average time for price targets to be met?

On average it took 63 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on SQZ (Sqz Biotechnologies Co) with a proven track record?

GEULAH LIVSHITS

Which analyst has the current lower performing score on SQZ (Sqz Biotechnologies Co) with a proven track record?

TAZEEN AHMAD

Which analyst has the most public recommendations on SQZ (Sqz Biotechnologies Co)?

Geulah Livshits works at CHARDAN CAPITAL and has 15 price targets and 14 ratings on SQZ

Which analyst is the currently most bullish on SQZ (Sqz Biotechnologies Co)?

Geulah Livshits with highest potential upside - $3.95

Which analyst is the currently most reserved on SQZ (Sqz Biotechnologies Co)?

Thomas Shrader with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?